tiprankstipranks
Trending News
More News >
Lifecore Biomedical (LFCR)
NASDAQ:LFCR
Advertisement

Lifecore Biomedical (LFCR) Stock Statistics & Valuation Metrics

Compare
147 Followers

Total Valuation

Lifecore Biomedical has a market cap or net worth of $243.16M. The enterprise value is $418.81M.
Market Cap$243.16M
Enterprise Value$418.81M

Share Statistics

Lifecore Biomedical has 37,466,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,466,350
Owned by Insiders29.92%
Owned by Institutions45.88%

Financial Efficiency

Lifecore Biomedical’s return on equity (ROE) is -0.82 and return on invested capital (ROIC) is -18.20%.
Return on Equity (ROE)-0.82
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-18.20%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee245.93K
Profits Per Employee-73.89K
Employee Count524
Asset Turnover0.54
Inventory Turnover2.74

Valuation Ratios

The current PE Ratio of Lifecore Biomedical is ―. Lifecore Biomedical’s PEG ratio is 0.01.
PE Ratio
PS Ratio1.82
PB Ratio4.93
Price to Fair Value4.93
Price to FCF-17.18
Price to Operating Cash Flow-1.17K
PEG Ratio0.01

Income Statement

In the last 12 months, Lifecore Biomedical had revenue of 128.87M and earned -38.72M in profits. Earnings per share was -1.27.
Revenue128.87M
Gross Profit40.30M
Operating Income-38.72M
Pretax Income-38.67M
Net Income-38.72M
EBITDA-8.81M
Earnings Per Share (EPS)-1.27

Cash Flow

In the last 12 months, operating cash flow was -206.00K and capital expenditures -13.41M, giving a free cash flow of -13.62M billion.
Operating Cash Flow-206.00K
Free Cash Flow-13.62M
Free Cash Flow per Share-0.36

Dividends & Yields

Lifecore Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.87
52-Week Price Change23.62%
50-Day Moving Average7.29
200-Day Moving Average6.85
Relative Strength Index (RSI)37.91
Average Volume (3m)204.26K

Important Dates

Lifecore Biomedical upcoming earnings date is Oct 3, 2025, After Close (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateOct 3, 2025
Ex-Dividend Date

Financial Position

Lifecore Biomedical as a current ratio of 2.84, with Debt / Equity ratio of 275.81%
Current Ratio2.84
Quick Ratio1.77
Debt to Market Cap0.56
Net Debt to EBITDA-13.91
Interest Coverage Ratio-1.77

Taxes

In the past 12 months, Lifecore Biomedical has paid 43.00K in taxes.
Income Tax43.00K
Effective Tax Rate>-0.01

Enterprise Valuation

Lifecore Biomedical EV to EBITDA ratio is -40.46, with an EV/FCF ratio of -26.18.
EV to Sales2.77
EV to EBITDA-40.46
EV to Free Cash Flow-26.18
EV to Operating Cash Flow-1.73K

Balance Sheet

Lifecore Biomedical has $8.27M in cash and marketable securities with $130.82M in debt, giving a net cash position of -$122.56M billion.
Cash & Marketable Securities$8.27M
Total Debt$130.82M
Net Cash-$122.56M
Net Cash Per Share-$3.27
Tangible Book Value Per Share$0.84

Margins

Gross margin is 31.27%, with operating margin of -30.04%, and net profit margin of -30.04%.
Gross Margin31.27%
Operating Margin-30.04%
Pretax Margin-30.01%
Net Profit Margin-30.04%
EBITDA Margin-6.84%
EBIT Margin-13.07%

Analyst Forecast

The average price target for Lifecore Biomedical is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside54.08% Upside
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast0.47%
EPS Growth Forecast-430.88%

Scores

Smart Score6
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis